Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Syapse Appoints David Pomerantz as Chief Commercial Officer

Accomplished Executive Leader in Real-World Evidence Joins Executive Team to Lead Commercial Expansion

Syapse, a real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health Network, announced the appointment of David Pomerantz as Chief Commercial Officer. Mr. Pomerantz brings more than 25 years of account management, commercial and operational experience in the area of real-world evidence for life sciences having most recently come from Kantar Health, a leader in providing data, analytics and research to the life sciences industry.

Recommended AI News: Merge Releases Hand-Held Digital Teaching Aids

“David has a successful track record partnering with pharmaceutical and biotech manufacturers to commercialize treatments and demonstrate their real-world effectiveness,” said Ken Tarkoff, chief executive officer at Syapse. “As we expand our life science partnerships across the Syapse Learning Health Network, David will lead the strategic direction of Syapse’s commercial endeavors and will be a valued asset to our leadership team. I’m pleased to welcome him to Syapse and look forward to his contributions as we create opportunities to use real-world evidence to improve the outcomes of cancer patients.”

Related Posts
1 of 27,645

Recommended AI News: MediaTek Advances Its 5G Platform With New T750 5G Chipset for Fixed Wireless Access Routers

While at Kantar Health for more than a decade, Mr. Pomerantz held increasingly responsible commercial operations positions including leadership of the RWE Client Partner sales team for the Americas and Europe. Most notably, he was responsible for the identification, acquisition and integration of the healthcare consulting firm, Evidencias, now a Kantar Health company, a leader in evidence-based health management services in Brazil focused on oncology and real-world evidence. Under his leadership, Kantar Health successfully entered into an emerging market and bridged the gap between life sciences, payers, providers and regulators.

“Syapse’s mission of using real-world evidence to improve outcomes for patients with cancer is aligned with my passion to innovate patient care by partnering with life sciences companies, health systems and regulators to take action on real-world data insights,” said David Pomerantz, Chief Commercial Officer. “I’m excited to join Syapse in their mission to empower life sciences and health systems to bring the power of precision medicine to patients who need it.”

Recommended AI News: How Carlsberg India Tracked Employee Health During COVID-19 With PeopleStrong Alt

Leave A Reply

Your email address will not be published.